INDUCED HUMORAL IMMUNE RESPONSE USING PROMOTERS SPECIFICALLY ACTIVE IN ANTIGEN PRESENTING CELLS

Details for Australian Patent Application No. 2003283139 (hide)

Owner D.COLLEN RESEARCH FOUNDATION VZW

Inventors DE GEEST, Bart; VAN LINTHOUT, Sophie; COLLEN, Desire

Pub. Number AU-A-2003283139

PCT Number PCT/BE2003/0002

PCT Pub. Number WO2004/046363

Priority 0226717.7 15.11.02 GB

Filing date 17 November 2003

Wipo publication date 15 June 2004

International Classifications

C12N 015/85 Mutation or genetic engineering - for animal cells

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 015/86 Mutation or genetic engineering - Viral vectors

C07K 014/705 Peptides having more than 20 amino acids

C07K 014/775 Peptides having more than 20 amino acids

C07K 014/47 Peptides having more than 20 amino acids

Event Publications

25 March 2004 Complete Application Filed

  Priority application(s): 0226717.7 15.11.02 GB

15 July 2004 Application Open to Public Inspection

  Published as AU-A-2003283139

4 August 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003283140-COST-AWARE DESIGNTIME/RUN-TIME MEMORY MANAGEMENT METHODS AND APPARATUS

2003283138-THERAPEUTIC POLYPEPTDIDES, HOMOLOGUES THEREOF, FRAGMENTS THEREOF AND FOR USE IN MODULATING PLATELET MEDIATED AGGREGATION